immunotherapybreast cancerIFN-γinterferon-gamma
…i-tumor immune responses, which could influence the response to immunotherapy.Methods We aimed to determine the impact of heat-inactivated ba…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 601–660 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Non-operative Treatment Strategy2Multidisciplinary pain management2Insulin pump therapy2LDKT2DDKT2appendectomy2Pericardiocentesis2TVE2ChT2Cryoablation2Deprescribing2EndoFLIP2alternative treatment2COMBO2Procedural Sedation2csDMARDs2dCBT-I2CNA2FIT2McKenzie method2Medication reconciliation2Metabolic-bariatric surgery2PCA2POBA2CARTA2CRFA2HFNC2LT-NIV2SRS2Sharp debridement2head and neck radiotherapy2LLETZ2PRP2Respiratory physiotherapy2Respiratory rehabilitation2SRFA2nasal packing2prophylaxis2Cryoneurolysis2Fibrinolysis2Inhalers2T-FUS2AVT2Adenotonsillectomy2BT2Contrast enema2HMV2IFD2KRT2PR-buddy2Placenta-derived products2Vertebral augmentation2local consolidative therapy2neoadjuvant immunochemotherapy2neuraxial anaesthesia2rescue treatment2Autologous fat transfer2COT2Corticosteroid treatment2EMR2
Articles mentioning treatments
7,227 articles · page 129 of 603T cell-targeted immunotherapiescancer immunotherapiesphorbol 12-myristate 13-acetateionomycin
…Background Although T cell-targeted immunotherapies have achieved significant clinical success, a considerable prop…
neoadjuvant chemotherapyTNBCandrogen receptor antagonistsClinicalTrials.govtriple-negative breast cancersEMBASEMEDLINE
…mistry [IHC] ≥ 10%) on pathologic complete response (pCR) after neoadjuvant chemotherapy and synthesized immune-contexture data.Methods We performed a P…
immunotherapyimmunotherapy-relatedhepatocellular carcinomaHCCMinistry of Higher Education and ResearchFrench Data Protection Authority
…CC), with only 30% achieving complete pathological responses to immunotherapy. While transcriptomic profiling has identified HCC subgroups li…
Chimeric antigen receptor (CAR) T therapyCART therapyRhabdomyosarcomacyclophosphamidesolid tumorsRMS
…Background Chimeric antigen receptor (CAR) T therapy has seen limited success in patients with solid tumors, likely …
CAR-T therapyGlioblastomaGBMNational Natural Science Foundation of China GrantsGBM-bearingGRGZ2022330Southern Medical University Nanfang Hospital Experimental Animal CenterGRGZ20230520
…o address these limitations, this study aims to develop a novel CAR-T therapy strategy, which knocks out intracellular immune checkpoint CISH…
96.5%
CAR-T cell therapyCAR-T therapyColorectal cancerCRCsolid tumorsHEK293Human Protein AtlasCART87LS174Turokinase plasminogen activator (uPA)
…hs in the U.S., with rising incidence among young adults. While CAR-T cell therapy has been successful in treating some hematologic malignancies, …
CAR-T therapyCAR-NK therapyleukemiasolid tumorsFDAblood-based cancers
…ic CARs (Chimeric Antigen Receptors) to target cancerous cells. CAR-T therapy is largely limited to blood-based cancers, most commonly leukem…
CAR-T cell therapyCAR-T therapycheckpoint blockade immunotherapysolid tumorsmelanomarelapsed/refractory hematologic malignanciesId3-CARId3
…s in treating relapsed/refractory hematologic malignancies, and CAR-T cell therapy is being avidly pursued for treatment of solid tumors. However,…
CAR-NK therapyCAR-NK cell therapyhepatocellular carcinomasolid tumorsNational Natural Science Foundation of China GrantsHCCNanfang Hospitalhematologic malignanciesGRGZ2022330IL-15-armored CAR+1 more
…Background CAR-NK therapy holds great promise as a safe and effective strategy for hemato…
CAR T cell therapybezafibrateB cell malignancies
…Background CAR T cell therapy has revolutionized treatment outcomes for numerous B cell malig…
Cell therapiesrenal cell carcinomapancreatic adenocarcinomaVenetoclax
…Background Cell therapies are a promising approach to treat many types of cancers but bal…